Cardinal Health (NYSE: CAH), a global, integrated healthcare services and products company, has named Sheri Edison as its new independent director, effective 1 September, it was reported on Monday.
Presently, Edison holds the position of executive vice president and general counsel for Amcor plc. She has also served as senior vice president, chief legal officer and secretary for Bemis Company Inc, and senior vice president, chief administrative officer of Hill-Rom Holdings Inc and in multiple senior legal roles at other leading companies, and as an attorney in private practice. Edison also serves on the board of directors for American Family Insurance and on the Board of Visitors of the University of Wisconsin Waisman Center. She has also served on the board of directors of AK Steel, where she chaired the Nominating and Corporate Governance Committee.
Gregory Kenny, chairman of the board for Cardinal Health, said, 'We are very pleased to welcome Sheri as a director. Sheri brings both strong leadership experience across areas of legal and regulatory compliance and corporate governance as well as a healthcare industry background that complement the experiences and skillsets of our current directors. She has led a number of critical business functions and initiatives, including IT and strategic planning efforts during her career, and we look forward to benefitting from her deep expertise and knowledge of complex businesses.'
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'
IVFMD physicians named 2025 Castle Connolly Top Doctors
HOPE Therapeutics and NRx Pharmaceuticals select BTIG as financial advisor
Partillion Bioscience opens pre-orders for Nanovial Multicell Assay Antibody Discovery Kits
Champions Oncology expands bioanalytical services with new technology
Petauri's Nicole Lodowski named to MM+M's 40 Under 40 for 2025
WuXi XDC Cayman wins 'Best CDMO' at World ADC Awards 2024
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business